Barclays’s Bain Capital Specialty BCSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,900
Closed -$31.5K 5262
2025
Q1
$31.5K Buy
+1,900
New +$33.5K ﹤0.01% 4710
2024
Q1
Sell
-6,455
Closed -$97.3K 5077
2023
Q4
$97.3K Buy
+6,455
New +$98.2K ﹤0.01% 4639
2021
Q4
Sell
-344
Closed -$5K 4140
2021
Q3
$5K Sell
344
-164
-32% -$2.49K ﹤0.01% 4595
2021
Q2
$8K Buy
508
+308
+154% +$4.86K ﹤0.01% 4687
2021
Q1
$3K Buy
+200
New +$2.76K ﹤0.01% 4519
2020
Q3
Sell
-70
Closed -$1K 5215
2020
Q2
$1K Buy
+70
New +$724 ﹤0.01% 5466
2020
Q1
Sell
-31
Closed -$1K 6137
2019
Q4
$1K Buy
+31
New +$583 ﹤0.01% 6267
2019
Q2
Sell
-3,377
Closed -$64K 6942
2019
Q1
$64K Buy
+3,377
New +$63.4K ﹤0.01% 5694

Other funds holding BCSF

Barclays's BCSF Position: Q2 2025 in Review

Barclays sold out of Bain Capital Specialty (BCSF) in Q2 2025, closing a stake of 1,900 shares — an estimated $31.5K sold.

Barclays first reported a position in BCSF in Q1 2019 and held it in 8 quarters. The position peaked at $97.3K in Q4 2023. 143 funds tracked by Wall St. Rank hold BCSF as of Q2 2025.

  • Barclays reported no remaining Bain Capital Specialty position as of Q2 2025 after selling out during the quarter.
  • Barclays sold 1,900 Bain Capital Specialty shares in Q2 2025, an estimated $31.5K.
  • Barclays first reported a position in Bain Capital Specialty in Q1 2019 and held it in 8 quarters.
  • Barclays's Bain Capital Specialty position peaked at $97.3K in Q4 2023.
  • 143 funds tracked by Wall St. Rank held Bain Capital Specialty as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.